Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Organogenesis (ORGO) had Operating Cash Flow per Share of $0.23 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$433.14M |
|
$4.95M |
|
$106.48M |
|
$326.66M |
|
$420.62M |
|
$12.53M |
|
$-2.13M |
|
$10.39M |
|
$10.39M |
|
$4.95M |
|
$4.95M |
|
$4.95M |
|
$4.95M |
|
$12.53M |
|
$35.97M |
|
131.23M |
|
132.75M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$225.04M |
|
$116.23M |
|
$234.98M |
|
$460.02M |
|
$80.51M |
|
$62.63M |
|
$100.85M |
|
$181.36M |
|
$278.66M |
|
$234.02M |
|
$278.66M |
|
131.32M |
|
| Cash Flow Statement Financials | |
$30.92M |
|
$-24.36M |
|
$-5.50M |
|
$103.29M |
|
$104.34M |
|
$1.05M |
|
$9.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.80 |
|
-- |
|
-- |
|
0.18 |
|
0.25 |
|
75.42% |
|
2.89% |
|
2.89% |
|
8.31% |
|
2.40% |
|
1.14% |
|
$6.55M |
|
-- |
|
-- |
|
-- |
|
0.94 |
|
3.77 |
|
5.28 |
|
69.10 |
|
1.77% |
|
2.11% |
|
1.07% |
|
1.45% |
|
$2.12 |
|
$0.05 |
|
|
Operating Cash Flow per Share |
$0.23 |